0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query ark patent intelligence metformin dapagliflozin patent extension data exclusivity expiry 1.Your search for "" gave back 1493320 results.
Dapagliflozin is a medication used to treat type 2 diabetes and, with certain restrictions, type 1 diabetes. The global Dapagliflozin API market was...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Biogenerics drugs are the biological products manufactured after end of patent of innovator biopharmaceuticals. Biogenerics also known as biosimilars...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Parathyroid hormone/parathyroid hormone-related peptide receptor also known as parathyroid hormone 1 receptor (PTH1R) functions as a receptor for...
Catalog:
La Merie Publishing
October 2013
Price: USD 265.00
The present Competitive Intelligence Report about Her2 Antibodies - Trastuzumab Biosimilars and Biobetters/Biosuperiors provides a competitor...
Catalog:
La Merie Publishing
February 2014
Price: USD 413.00
VEGF Antibodies – Bevacizumab and Ranibizumab Biosimilars and Biosuperiors The present Competitive Intelligence Report about VEGF Antibodies –...
Catalog:
La Merie Publishing
February 2014
Price: USD 401.00
This Competitive Intelligence Report about CD20 Antibodies 2015- Biosimilars and Biosuperiors of Rituximab provides a competitor evaluation in the...
Catalog:
La Merie Publishing
March 2015
Price: USD 346.00
U.S. (United States) pharmaceutical market is the largest pharmaceuticals market in the world and accounted for more than 40% global pharmaceuticals...
Catalog:
NAVADHI
March 2019
Price: USD 3,500.00
Biogenerics drugs are the biological products manufactured after end of patent of innovator biopharmaceuticals. Biogenerics also known as biosimilars...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
This Competitive Intelligence Report about VEGF and VEGF-R Antibodies 2015 - Biosimilars and Biosuperiors of Avastin and Lucentis provides a...
Catalog:
La Merie Publishing
February 2015
Price: USD 460.00
Metformin, marketed under the trade name Glucophage among others, is the first-line medication for the treatment of type 2 diabetes, particularly in...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Metformin oral tablet comes in two forms: immediate-release and extended-release. The immediate-release tablet is available as a generic drug. The...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Metformin, marketed under the trade name Glucophage among others, is the first-line medication for the treatment of type 2 diabetes, particularly in...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Metformin, marketed under the trade name Glucophage among others, is the first-line medication for the treatment of type 2 diabetes, particularly in...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Polymerase Chain Reaction (PCR) is a novel technique which doubles the amount of target DNA in every cycle. The PCR has three steps such as...
Catalog:
IQ4I
May 2016
Price: USD 4,500.00
Biosimilar and Biosuperior Therapeutic Antibodies 2014 The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic...
Catalog:
La Merie Publishing
March 2014
Price: USD 1,514.00
